Annual Total Assets
$465.63 M
+$112.89 M+32.00%
31 December 2023
Summary:
Celldex Therapeutics annual total assets is currently $465.63 million, with the most recent change of +$112.89 million (+32.00%) on 31 December 2023. During the last 3 years, it has risen by +$229.79 million (+97.44%). CLDX annual total assets is now at all-time high.CLDX Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Assets
$823.18 M
-$22.41 M-2.65%
01 September 2024
Summary:
Celldex Therapeutics quarterly total assets is currently $823.18 million, with the most recent change of -$22.41 million (-2.65%) on 01 September 2024. Over the past year, it has increased by +$542.92 million (+193.72%). CLDX quarterly total assets is now -5.26% below its all-time high of $868.85 million, reached on 31 March 2024.CLDX Quarterly Total Assets Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CLDX Total Assets Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +32.0% | +193.7% |
| 3 y3 years | +97.4% | +78.9% |
| 5 y5 years | +198.8% | +524.4% |
CLDX Total Assets High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | at high | +97.4% | -5.3% | +193.7% |
| 5 y | 5 years | at high | +278.8% | -5.3% | +631.7% |
| alltime | all time | at high | >+9999.0% | -5.3% | >+9999.0% |
Celldex Therapeutics Total Assets History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $823.18 M(-2.6%) |
| June 2024 | - | $845.59 M(-2.7%) |
| Mar 2024 | - | $868.85 M(+86.6%) |
| Dec 2023 | $465.63 M(+32.0%) | $465.63 M(+66.1%) |
| Sept 2023 | - | $280.26 M(-6.4%) |
| June 2023 | - | $299.31 M(-7.8%) |
| Mar 2023 | - | $324.52 M(-8.0%) |
| Dec 2022 | $352.74 M(-20.7%) | $352.74 M(-4.5%) |
| Sept 2022 | - | $369.23 M(-8.4%) |
| June 2022 | - | $402.96 M(-5.0%) |
| Mar 2022 | - | $424.04 M(-4.6%) |
| Dec 2021 | $444.65 M(+88.5%) | $444.65 M(-3.4%) |
| Sept 2021 | - | $460.20 M(+125.0%) |
| June 2021 | - | $204.55 M(-6.6%) |
| Mar 2021 | - | $219.06 M(-7.1%) |
| Dec 2020 | $235.84 M(+91.8%) | $235.84 M(-7.8%) |
| Sept 2020 | - | $255.77 M(-2.2%) |
| June 2020 | - | $261.40 M(+132.3%) |
| Mar 2020 | - | $112.50 M(-8.5%) |
| Dec 2019 | $122.93 M(-21.1%) | $122.93 M(-6.8%) |
| Sept 2019 | - | $131.84 M(-7.3%) |
| June 2019 | - | $142.24 M(-3.6%) |
| Mar 2019 | - | $147.58 M(-5.3%) |
| Dec 2018 | $155.81 M(-50.6%) | $155.81 M(-7.4%) |
| Sept 2018 | - | $168.29 M(-5.7%) |
| June 2018 | - | $178.38 M(-6.8%) |
| Mar 2018 | - | $191.38 M(-39.4%) |
| Dec 2017 | $315.62 M(-17.7%) | $315.62 M(-1.2%) |
| Sept 2017 | - | $319.42 M(-7.7%) |
| June 2017 | - | $346.07 M(-3.9%) |
| Mar 2017 | - | $360.05 M(-6.1%) |
| Dec 2016 | $383.36 M(+13.6%) | $383.36 M(+52.2%) |
| Sept 2016 | - | $251.95 M(-7.1%) |
| June 2016 | - | $271.21 M(-10.2%) |
| Mar 2016 | - | $301.93 M(-10.6%) |
| Dec 2015 | $337.58 M(+36.1%) | $337.58 M(-4.3%) |
| Sept 2015 | - | $352.63 M(-8.0%) |
| June 2015 | - | $383.22 M(-6.0%) |
| Mar 2015 | - | $407.70 M(+64.4%) |
| Dec 2014 | $248.01 M(-28.5%) | $248.01 M(-8.7%) |
| Sept 2014 | - | $271.67 M(-8.7%) |
| June 2014 | - | $297.59 M(-6.6%) |
| Mar 2014 | - | $318.70 M(-8.2%) |
| Dec 2013 | $347.10 M(+176.5%) | $347.10 M(+91.8%) |
| Sept 2013 | - | $180.96 M(-7.8%) |
| June 2013 | - | $196.23 M(-12.5%) |
| Mar 2013 | - | $224.37 M(+78.7%) |
| Dec 2012 | $125.54 M(+28.1%) | $125.54 M(+4.8%) |
| Sept 2012 | - | $119.84 M(-1.9%) |
| June 2012 | - | $122.13 M(-10.7%) |
| Mar 2012 | - | $136.74 M(+39.5%) |
| Dec 2011 | $97.99 M(-10.9%) | $97.99 M(-9.6%) |
| Sept 2011 | - | $108.45 M(-8.5%) |
| June 2011 | - | $118.48 M(+28.2%) |
| Mar 2011 | - | $92.40 M(-16.0%) |
| Dec 2010 | $109.94 M(-21.7%) | $109.94 M(-1.7%) |
| Sept 2010 | - | $111.81 M(-8.0%) |
| June 2010 | - | $121.57 M(-8.2%) |
| Mar 2010 | - | $132.44 M(-5.6%) |
| Dec 2009 | $140.36 M(+101.1%) | $140.36 M(+191.8%) |
| Sept 2009 | - | $48.10 M(-11.6%) |
| June 2009 | - | $54.41 M(-14.3%) |
| Mar 2009 | - | $63.48 M(-9.0%) |
| Dec 2008 | $69.79 M(+644.5%) | $69.79 M(-11.9%) |
| Sept 2008 | - | $79.19 M(-8.3%) |
| June 2008 | - | $86.34 M(+111.6%) |
| Mar 2008 | - | $40.80 M(+335.3%) |
| Dec 2007 | $9.37 M(-84.8%) | $9.37 M(-78.4%) |
| Sept 2007 | - | $43.40 M(-11.8%) |
| June 2007 | - | $49.21 M(-9.4%) |
| Mar 2007 | - | $54.34 M(-11.6%) |
| Dec 2006 | $61.48 M | $61.48 M(-4.0%) |
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2006 | - | $64.05 M(-6.6%) |
| June 2006 | - | $68.55 M(-6.5%) |
| Mar 2006 | - | $73.31 M(+101.1%) |
| Dec 2005 | $36.45 M(-20.4%) | $36.45 M(-9.0%) |
| Sept 2005 | - | $40.06 M(-9.9%) |
| June 2005 | - | $44.48 M(+10.7%) |
| Mar 2005 | - | $40.17 M(-12.3%) |
| Dec 2004 | $45.80 M(+46.3%) | $45.80 M(-0.7%) |
| Sept 2004 | - | $46.13 M(-5.7%) |
| June 2004 | - | $48.90 M(-6.6%) |
| Mar 2004 | - | $52.33 M(+67.2%) |
| Dec 2003 | $31.31 M(-11.1%) | $31.31 M(-11.0%) |
| Sept 2003 | - | $35.17 M(+22.2%) |
| June 2003 | - | $28.78 M(-10.1%) |
| Mar 2003 | - | $32.02 M(-9.1%) |
| Dec 2002 | $35.23 M(-34.1%) | $35.23 M(-8.9%) |
| Sept 2002 | - | $38.69 M(-8.5%) |
| June 2002 | - | $42.26 M(-11.4%) |
| Mar 2002 | - | $47.73 M(-10.8%) |
| Dec 2001 | $53.48 M(-15.9%) | $53.48 M(+14.8%) |
| Sept 2001 | - | $46.58 M(-12.7%) |
| June 2001 | - | $53.34 M(-8.1%) |
| Mar 2001 | - | $58.05 M(-8.7%) |
| Dec 2000 | $63.56 M(+219.7%) | $63.56 M(+18.0%) |
| Sept 2000 | - | $53.85 M(+150.3%) |
| June 2000 | - | $21.52 M(-12.4%) |
| Mar 2000 | - | $24.56 M(+23.5%) |
| Dec 1999 | $19.88 M(-12.2%) | $19.88 M(-15.0%) |
| Sept 1999 | - | $23.40 M(+41.8%) |
| June 1999 | - | $16.50 M(-16.2%) |
| Mar 1999 | - | $19.70 M(-13.0%) |
| Dec 1998 | $22.65 M(+131.1%) | $22.65 M(-9.8%) |
| Sept 1998 | - | $25.10 M(+156.1%) |
| June 1998 | - | $9.80 M(-15.5%) |
| Mar 1998 | - | $11.60 M(+18.4%) |
| Dec 1997 | $9.80 M(-43.0%) | $9.80 M(-14.8%) |
| Sept 1997 | - | $11.50 M(-14.2%) |
| June 1997 | - | $13.40 M(-10.7%) |
| Mar 1997 | - | $15.00 M(-12.8%) |
| Dec 1996 | $17.20 M(-7.0%) | $17.20 M(-10.9%) |
| Sept 1996 | - | $19.30 M(+65.0%) |
| June 1996 | - | $11.70 M(-27.3%) |
| Mar 1996 | - | $16.10 M(-13.0%) |
| Dec 1995 | $18.50 M(-10.6%) | $18.50 M(+58.1%) |
| Sept 1995 | - | $11.70 M(-21.5%) |
| June 1995 | - | $14.90 M(-17.2%) |
| Mar 1995 | - | $18.00 M(-13.0%) |
| Dec 1994 | $20.70 M(-37.5%) | $20.70 M(-18.2%) |
| Sept 1994 | - | $25.30 M(-9.0%) |
| June 1994 | - | $27.80 M(-9.4%) |
| Mar 1994 | - | $30.70 M(-7.3%) |
| Dec 1993 | $33.10 M(+47.8%) | $33.10 M(+92.4%) |
| Sept 1993 | - | $17.20 M(-10.4%) |
| June 1993 | - | $19.20 M(-8.6%) |
| Mar 1993 | - | $21.00 M(-13.9%) |
| Dec 1992 | $22.40 M(-17.0%) | - |
| Oct 1992 | - | $24.40 M(-5.8%) |
| July 1992 | - | $25.90 M(-4.1%) |
| Apr 1992 | - | $27.00 M(-3.6%) |
| Apr 1992 | $27.00 M(+104.5%) | - |
| Jan 1992 | - | $28.00 M(-1.4%) |
| Oct 1991 | - | $28.40 M(-4.7%) |
| July 1991 | - | $29.80 M(+125.8%) |
| Apr 1991 | $13.20 M(-15.4%) | $13.20 M(+3.9%) |
| Jan 1991 | - | $12.70 M(-5.9%) |
| Oct 1990 | - | $13.50 M(-11.2%) |
| July 1990 | - | $15.20 M(-2.6%) |
| Apr 1990 | $15.60 M(+18.2%) | $15.60 M(+32.2%) |
| Jan 1990 | - | $11.80 M(-10.6%) |
| Apr 1989 | $13.20 M(+1.5%) | $13.20 M(+1.5%) |
| Apr 1988 | $13.00 M(-11.0%) | $13.00 M(-11.0%) |
| Apr 1987 | $14.60 M(+356.3%) | $14.60 M(+356.3%) |
| Apr 1986 | $3.20 M | $3.20 M |
FAQ
- What is Celldex Therapeutics annual total assets?
- What is the all time high annual total assets for Celldex Therapeutics?
- What is Celldex Therapeutics annual total assets year-on-year change?
- What is Celldex Therapeutics quarterly total assets?
- What is the all time high quarterly total assets for Celldex Therapeutics?
- What is Celldex Therapeutics quarterly total assets year-on-year change?
What is Celldex Therapeutics annual total assets?
The current annual total assets of CLDX is $465.63 M
What is the all time high annual total assets for Celldex Therapeutics?
Celldex Therapeutics all-time high annual total assets is $465.63 M
What is Celldex Therapeutics annual total assets year-on-year change?
Over the past year, CLDX annual total assets has changed by +$112.89 M (+32.00%)
What is Celldex Therapeutics quarterly total assets?
The current quarterly total assets of CLDX is $823.18 M
What is the all time high quarterly total assets for Celldex Therapeutics?
Celldex Therapeutics all-time high quarterly total assets is $868.85 M
What is Celldex Therapeutics quarterly total assets year-on-year change?
Over the past year, CLDX quarterly total assets has changed by +$542.92 M (+193.72%)